AAAAAA

   
Results: 1-16 |
Results: 16
SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS
Authors: WALSH TJ YELDANDI V MCEVOY M GONZALEZ C CHANOCK S FREIFELD A SEIBEL NI WHITCOMB PO JAROSINSKI P BOSWELL G BEKERSKY I ALAK A BUELL D BARRET J WILSON W
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398
PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING
Authors: MUELLER BU ANDERSON BD FARLEY MQ MURPHY R ZUCKERMAN J JAROSINSKI P GODWIN K MCCULLY CL MITSUYA H PIZZO PA BALIS FM
Citation: Bu. Mueller et al., PHARMACOKINETICS OF THE PROTEASE INHIBITOR KNI-272 IN PLASMA AND CEREBROSPINAL-FLUID IN NONHUMAN-PRIMATES AFTER INTRAVENOUS DOSING AND IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AFTER INTRAVENOUS AND ORAL DOSING, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1815-1818
A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/
Authors: MUELLER BU NELSON RP SLEASMAN J ZUCKERMAN J HEATHCHIOZZI M STEINBERG SM BALIS FM BROUWERS P HSU A SAULIS R SEI S WOOD LV ZEICHNER S KATZ TTK HIGHAM C AKER D EDGERLY M JAROSINSKI P SERCHUCK L WHITCUP SM PIZZUTI D PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR RITONAVIR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/, Pediatrics, 101(3), 1998, pp. 335-343
SAFETY, TOLERANCE, AND PHARMACOKINETICS OF AMPHOTERICIN-B LIPID COMPLEX IN CHILDREN WITH HEPATOSPLENIC CANDIDIASIS
Authors: WALSH TJ WHITCOMB P PISCITELLI S FIGG WD HILL S CHANOCK SJ JAROSINSKI P GUPTA R PIZZO PA
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF AMPHOTERICIN-B LIPID COMPLEX IN CHILDREN WITH HEPATOSPLENIC CANDIDIASIS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1944-1948
RANDOMIZED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PEDIATRIC-PATIENTS RECEIVING INTENSIVE MYELOSUPPRESSIVE CHEMOTHERAPY
Authors: WEXLER LH WEAVERMCCLURE L STEINBERG SM JACOBSON J JAROSINSKI P AVILA N PIZZO PA HOROWITZ ME
Citation: Lh. Wexler et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PEDIATRIC-PATIENTS RECEIVING INTENSIVE MYELOSUPPRESSIVE CHEMOTHERAPY, Journal of clinical oncology, 14(3), 1996, pp. 901-910
RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN
Authors: WEXLER LH ANDRICH MP VENZON D BERG SL WEAVERMCCLURE L CHEN CC DILSIZIAN V AVILA N JAROSINSKI P BALIS FM POPLACK DG HOROWITZ ME
Citation: Lh. Wexler et al., RANDOMIZED TRIAL OF THE CARDIOPROTECTIVE AGENT ICRF-187 IN PEDIATRIC SARCOMA PATIENTS TREATED WITH DOXORUBICIN, Journal of clinical oncology, 14(2), 1996, pp. 362-372
LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/
Authors: LEWIS LL VENZON D CHURCH J FARLEY M WHEELER S KELLER A RUBIN M YUEN G MUELLER B SLOAS M WOOD L BALIS F SHEARER GM BROUWERS P GOLDSMITH J PIZZO PA ANDERSON B HIRSCHFELD S SEI S ZEICHNER S ROILIDES E CLERICI M WELLS M STOCKER V HIGHAM C TOWNLEY E WALSEK C ZWERSKI S HEILMAN N SELKINGUTMAN G WOLTERS P MOSS H JAROSINSKI P
Citation: Ll. Lewis et al., LAMIVUDINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PHASE I II STUDY/, The Journal of infectious diseases, 174(1), 1996, pp. 16-25
IFOSFAMIDE AND ETOPOSIDE PLUS VINCRISTINE, DOXORUBICIN, AND CYCLOPHOSPHAMIDE FOR NEWLY-DIAGNOSED EWINGS-SARCOMA FAMILY OF TUMORS
Authors: WEXLER LH DELANEY TF TSOKOS M AVILA N STEINBERG SM WEAVERMCCLURE L JACOBSON J JAROSINSKI P HIJAZI YM BALIS FM HOROWITZ ME
Citation: Lh. Wexler et al., IFOSFAMIDE AND ETOPOSIDE PLUS VINCRISTINE, DOXORUBICIN, AND CYCLOPHOSPHAMIDE FOR NEWLY-DIAGNOSED EWINGS-SARCOMA FAMILY OF TUMORS, Cancer, 78(4), 1996, pp. 901-911
MONOTHERAPY FOR FEVER AND NEUTROPENIA IN CANCER-PATIENTS - A RANDOMIZED COMPARISON OF CEFTAZIDIME VERSUS IMIPENEM
Authors: FREIFELD AG WALSH T MARSHALL D GRESS J STEINBERG SM HATHORN J RUBIN M JAROSINSKI P GILL V YOUNG RC PIZZO PA
Citation: Ag. Freifeld et al., MONOTHERAPY FOR FEVER AND NEUTROPENIA IN CANCER-PATIENTS - A RANDOMIZED COMPARISON OF CEFTAZIDIME VERSUS IMIPENEM, Journal of clinical oncology, 13(1), 1995, pp. 165-176
A PROSPECTIVE EVALUATION OF IFOSFAMIDE-RELATED NEPHROTOXICITY IN CHILDREN AND YOUNG-ADULTS
Authors: HO PTC ZIMMERMAN K WEXLER LH BLANEY S JAROSINSKI P WEAVERMCCLURE L IZRAELI S BALIS FM
Citation: Ptc. Ho et al., A PROSPECTIVE EVALUATION OF IFOSFAMIDE-RELATED NEPHROTOXICITY IN CHILDREN AND YOUNG-ADULTS, Cancer, 76(12), 1995, pp. 2557-2564
ERYTHROPOIETIN FOR ZIDOVUDINE-ASSOCIATED ANEMIA IN CHILDREN WITH HIV-INFECTION
Authors: MUELLER BU JACOBSEN F JAROSINSKI P LEWIS LL PIZZO PA
Citation: Bu. Mueller et al., ERYTHROPOIETIN FOR ZIDOVUDINE-ASSOCIATED ANEMIA IN CHILDREN WITH HIV-INFECTION, Pediatric AIDS and HIV infection, 5(3), 1994, pp. 169-173
CLINICAL AND PHARMACOKINETIC EVALUATION OF LONG-TERM THERAPY WITH DIDANOSINE IN CHILDREN WITH HIV-INFECTION
Authors: MUELLER BU BUTLER KM STOCKER VL BALIS FM BROUWERS P JAROSINSKI P HUSSON RN LEWIS LL VENZON D PIZZO PA
Citation: Bu. Mueller et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF LONG-TERM THERAPY WITH DIDANOSINE IN CHILDREN WITH HIV-INFECTION, Pediatrics, 94(5), 1994, pp. 724-731
CLINICAL AND PHARMACOKINETIC EVALUATION OF LONG-TERM THERAPY WITH DIDANOSINE IN CHILDREN WITH HIV-INFECTION
Authors: MUELLER BU BUTLER KM STOCKER VL BALIS FM BROUWERS P JAROSINSKI P HUSSON RN LEWIS LL VENZON D PIZZO PA
Citation: Bu. Mueller et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF LONG-TERM THERAPY WITH DIDANOSINE IN CHILDREN WITH HIV-INFECTION, Pediatrics, 94(5), 1994, pp. 724-731
ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: HUSSON RN MUELLER BU FARLEY M WOODS L KOVACS A GOLDSMITH JC ONO J LEWIS LL BALIS FM BROUWERS P AVRAMIS VI CHURCH JA BUTLER KM RASHEED S JAROSINSKI P VENZON D PIZZO PA
Citation: Rn. Husson et al., ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Pediatrics, 93(2), 1994, pp. 316-322
PHARMACOKINETIC EVALUATION OF THE COMBINATION OF ZIDOVUDINE AND DIDANOSINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: MUELLER BU PIZZO PA FARLEY M HUSSON RN GOLDSMITH J KOVACS A WOODS L ONO J CHURCH JA BROUWERS P JAROSINSKI P VENZON D BALIS FM
Citation: Bu. Mueller et al., PHARMACOKINETIC EVALUATION OF THE COMBINATION OF ZIDOVUDINE AND DIDANOSINE IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of pediatrics, 125(1), 1994, pp. 142-146
DRUG-INTERACTION OF TERFENADINE AND CARBAMAZEPINE
Authors: HIRSCHFELD S JAROSINSKI P
Citation: S. Hirschfeld et P. Jarosinski, DRUG-INTERACTION OF TERFENADINE AND CARBAMAZEPINE, Annals of internal medicine, 118(11), 1993, pp. 907-908
Risultati: 1-16 |